New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Poster Presentation on Technical Sourcing’s PEAK ATP(TM) Wins First Place at Natural Supplements Conference

MISSOULA, MT (January 13, 2005) – Technical Sourcing International, Inc. (TSI) announced today that its proprietary PEAK ATP™ ingredient was the subject of a winning poster presentation at the second annual Natural Supplements: An Evidence-Based Update conference, organized by the Scripps Center for Integrative Medicine and co-sponsored by the University of California, San Diego, which took place January 7-9 in San Diego. The human clinical trial provided evidence that a single oral dose of PEAK ATP (adenosine triphosphate) increased peripheral perfusion pressure and oxygenation in healthy men and women, indicating the ingredient may be an effective treatment for patients with peripheral arterial disease (PAD), the most common manifestation of systemic atherosclerosis.

The conference, whose objective was to present a concise, clinically relevant overview of natural supplements in evidence-based practice, hosted a research competition to acknowledge new research in the area of natural supplement use in three categories: original clinical research, comprehensive review of existing research, and student research.

The PEAK ATP study, entitled “A Prospective, Randomized, Double Blind Study to Evaluate the Effect of Orally Administered Adenosine Triphosphate on Peripheral Perfusion Pressure in Adult Men and Women,” and performed by the Minnesota Applied Research Center (MARC), won the award in the category of original clinical research. Key considerations were basis of trial design, originality, and potential for future application. The poster was presented by John L. Zenk, MD, Chief Medical Officer, Joy L. Frestedt, PhD, Executive Director of Research, Sandra A. Leikam, RN, CCRC, and Sinoun Tep of MARC and Michael A. Kuskowski, PhD, of the Veterans Administration Medical Center, Minneapolis, MN. The abstract will be published in the Journal of Complementary and Alternative Medicine. A full-length publication of the trial results is expected later this year.

Twelve healthy men and women with a mean age of 49.7 years participated in the study. Each participant was administered three treatments over the course of three one-hour visits – placebo, PEAK ATP 100 mg and PEAK ATP 250 mg. Participants were randomized to receive each treatment in a crossover study design with a 7-day washout period between treatments. Arterial systolic pressure, pulse measurements of arterial blood oxygen saturation, and electrocardiogram were obtained at baseline, as well as one hour before and one hour after administration of the test substance. PEAK ATP administration effectively increased upper and lower extremity perfusion pressure as well as upper extremity oxygenation. The researchers concluded that “oral administration of ATP may be a safe and effective treatment to increase peripheral perfusion pressure and oxygenation in patients with PAD.”

PEAK ATP is the first legitimate entry of supplemental ATP into the marketplace and the only ATP clinically tested to demonstrate its effectiveness. Additionally, PEAK ATP is the only ATP backed by the unique portfolio of ATP patents developed through decades of exhaustive research by Dr. Eliezer Rapaport, considered one of the world’s foremost authorities on ATP.

About Technical Sourcing International, Inc.
Technical Sourcing International, Inc. (TSI) is a leading researcher, producer, and marketer of nutraceutical ingredients to the dietary supplement, pharmaceutical, and food and beverage industries. Its products include Promilin®, PEAK ATP™, OstivoneÒ, MSV 60Ò, Ginkgo 24/6/5ä, Rusperin Cä, PUREFLEXÒ Chondroitin and Glucosamine, as well as botanical, marine, and natural product extracts and synthesized compounds. The company is based in Missoula, Mont., and can be reached at (406) 549-9123 or

About MARC

The Minnesota Applied Research Center (MARC) is a clinical research facility founded in 1999 for the purpose of providing professional, timely and cost effective research for the dietary supplement industry. MARC is a fully equipped clinical research site with the ability to provide a full range of research services and take a research idea from conception to completion in a proficient and prompt manner. In addition, MARC frequently provides consulting services for the design and conduct of clinical trials, the review and monitoring of ongoing trials, as well as the documentation and submission of the trial results for publication or claims support.

# # #

Liz Smith, Marketing Manager
Technical Sourcing International, Inc.
(406) 549-9123

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.